326 related articles for article (PubMed ID: 10068525)
1. Complement component C3 production in IL-1beta-stimulated human intestinal epithelial cells is blocked by NF-kappaB inhibitors and by transfection with ser 32/36 mutant IkappaBalpha.
Moon MR; Parikh AA; Pritts TA; Fischer JE; Cottongim S; Szabo C; Salzman AL; Hasselgren PO
J Surg Res; 1999 Mar; 82(1):48-55. PubMed ID: 10068525
[TBL] [Abstract][Full Text] [Related]
2. IL-6 production in human intestinal epithelial cells following stimulation with IL-1 beta is associated with activation of the transcription factor NF-kappa B.
Parikh AA; Salzman AL; Kane CD; Fischer JE; Hasselgren PO
J Surg Res; 1997 Apr; 69(1):139-44. PubMed ID: 9202660
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of NF-kappaB by IkappaB prevents cytokine-induced NO production and promotes enterocyte apoptosis in vitro.
Potoka DA; Nadler EP; Zhou X; Zhang XR; Upperman JS; Ford HR
Shock; 2000 Sep; 14(3):366-73. PubMed ID: 11028558
[TBL] [Abstract][Full Text] [Related]
4. IL-1beta induction of NF-kappaB activation in human intestinal epithelial cells is independent of oxyradical signaling.
Parikh AA; Moon MR; Pritts TA; Fischer JE; Szabó C; Hasselgren PO; Salzman AL
Shock; 2000 Jan; 13(1):8-13. PubMed ID: 10638662
[TBL] [Abstract][Full Text] [Related]
5. Transient nuclear factor kappaB (NF-kappaB) activation stimulated by interleukin-1beta may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the IkappaBalpha molecule, in C6 glioma cells. Regulation of NF-kappaB linked to chemokine production.
Uehara T; Matsuno J; Kaneko M; Nishiya T; Fujimuro M; Yokosawa H; Nomura Y
J Biol Chem; 1999 May; 274(22):15875-82. PubMed ID: 10336492
[TBL] [Abstract][Full Text] [Related]
6. Stress response decreases the interleukin-1beta-induced production of complement component C3 in human intestinal epithelial cells.
Moon R; Pritts TA; Parikh AA; Fischer JE; Salzman AL; Ryan M; Wong HR; Hasselgren PO
Clin Sci (Lond); 1999 Sep; 97(3):331-7. PubMed ID: 10464058
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1beta induces complement component C3 and IL-6 production at the basolateral and apical membranes in a human intestinal epithelial cell line.
Moon MR; Parikh AA; Pritts TA; Kane C; Fischer JE; Salzman AL; Hasselgren PO
Shock; 2000 May; 13(5):374-8. PubMed ID: 10807012
[TBL] [Abstract][Full Text] [Related]
8. N-Acetyl-L-cysteine and pyrrolidine dithiocarbamate inhibited nuclear factor-kappaB activation in alveolar macrophages by different mechanisms.
Li YQ; Zhang ZX; Xu YJ; Ni W; Chen SX; Yang Z; Ma D
Acta Pharmacol Sin; 2006 Mar; 27(3):339-46. PubMed ID: 16490171
[TBL] [Abstract][Full Text] [Related]
9. Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells.
Jobin C; Haskill S; Mayer L; Panja A; Sartor RB
J Immunol; 1997 Jan; 158(1):226-34. PubMed ID: 8977194
[TBL] [Abstract][Full Text] [Related]
10. IL-1beta causes an increase in intestinal epithelial tight junction permeability.
Al-Sadi RM; Ma TY
J Immunol; 2007 Apr; 178(7):4641-9. PubMed ID: 17372023
[TBL] [Abstract][Full Text] [Related]
11. Arsenite stabilizes IkappaBalpha and prevents NF-kappaB activation in IL-1 beta-stimulated Caco-2 cells independent of the heat shock response.
Hershko DD; Robb BW; Hungness ES; Luo G; Hasselgren PO
J Cell Biochem; 2002; 84(4):687-98. PubMed ID: 11835394
[TBL] [Abstract][Full Text] [Related]
12. Pyrrolidine dithiocarbamate, a NF-kappaB inhibitor, upregulates MMP-1 and MMP-13 in IL-1beta-stimulated rheumatoid arthritis fibroblast-like synoviocytes.
Kim KS; Oh DH; Choi HM; Bang JS; Ryu CJ; Kim JH; Yoo MC; Yang HI
Eur J Pharmacol; 2009 Jun; 613(1-3):167-75. PubMed ID: 19379726
[TBL] [Abstract][Full Text] [Related]
13. Suppression of NF-kappaB-dependent proinflammatory gene expression in human RPE cells by a proteasome inhibitor.
Wang XC; Jobin C; Allen JB; Roberts WL; Jaffe GJ
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):477-86. PubMed ID: 9950608
[TBL] [Abstract][Full Text] [Related]
14. The NF-kappaB inhibitor pyrrolidine dithiocarbamate blocks IL-1beta induced hyaluronan synthase 1 (HAS1) mRNA transcription, pointing at NF-kappaB dependence of the gene HAS1.
Kao JJ
Exp Gerontol; 2006 Jun; 41(6):641-7. PubMed ID: 16723203
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB.
Singh R; Ahmed S; Islam N; Goldberg VM; Haqqi TM
Arthritis Rheum; 2002 Aug; 46(8):2079-86. PubMed ID: 12209512
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibitors block VCAM-1 and ICAM-1 gene expression in endothelial cells without affecting nuclear translocation of nuclear factor-kappa B.
Cobb RR; Felts KA; Parry GC; Mackman N
Eur J Immunol; 1996 Apr; 26(4):839-45. PubMed ID: 8625976
[TBL] [Abstract][Full Text] [Related]
17. Complement C3 production in human intestinal epithelial cells is regulated by interleukin 1beta and tumor necrosis factor alpha.
Moon R; Parikh AA; Szabo C; Fischer JE; Salzman AL; Hasselgren PO
Arch Surg; 1997 Dec; 132(12):1289-93. PubMed ID: 9403532
[TBL] [Abstract][Full Text] [Related]
18. Differential IkappaB kinase activation and IkappaBalpha degradation by interleukin-1beta and tumor necrosis factor-alpha in human U937 monocytic cells. Evidence for additional regulatory steps in kappaB-dependent transcription.
Nasuhara Y; Adcock IM; Catley M; Barnes PJ; Newton R
J Biol Chem; 1999 Jul; 274(28):19965-72. PubMed ID: 10391945
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells through inhibition of nuclear factor-kappaB by an IkappaBalpha "super-repressor".
Muenchen HJ; Lin DL; Walsh MA; Keller ET; Pienta KJ
Clin Cancer Res; 2000 May; 6(5):1969-77. PubMed ID: 10815922
[TBL] [Abstract][Full Text] [Related]
20. Persistent depletion of I kappa B alpha and interleukin-8 expression in human pulmonary epithelial cells exposed to quartz particles.
Schins RP; McAlinden A; MacNee W; Jimenez LA; Ross JA; Guy K; Faux SP; Donaldson K
Toxicol Appl Pharmacol; 2000 Sep; 167(2):107-17. PubMed ID: 10964761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
